MedPath

Comparison of Analgesic Efficacy of US Guided ESP Block With Port Site Infiltration Following Laparoscopic Cholecystectomy

Not Applicable
Completed
Conditions
Postoperative Pain
Interventions
Procedure: Port site infiltration
Procedure: Erector spinae plane block
Device: Ultrasound machine (Mindray DP 9900 plus; Mindray Bio-Medical Electronics, Shenzhen, China)
Registration Number
NCT04167176
Lead Sponsor
Assiut University
Brief Summary

To compare the efficacy of ultrasonography (USG)-guided bilateral Erector spinae plane block (ESPB) with port-site infiltration using bupivacaine for post-operative analgesia after laparoscopic cholecystectomy with a hypothesis that both Erector spinae plane block and port-site infiltration are effective in providing post-operative analgesia.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
44
Inclusion Criteria
  • patients with the American Society of Anesthesiologists (ASA) physical status I/II,
  • Age between 18 and 60 years with a body mass index (BMI) of 18-35 kg/m2,
  • Patients scheduled for elective laparoscopic cholecystectomy.
Exclusion Criteria
  • Allergy to local anaesthetics,

  • Infection at the site of injection,

    •, Coagulopathy,

  • Chronic pain syndromes,

  • Prolonged opioid medication,

  • Patients who received any analgesic 24 h before surgery

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Port site infiltration techniqueLidocaine 2%After the induction of anaesthesia, pre-incisional port-site infiltration will be performed by the same surgeon every time with 20 ml of Local anesthetic (LA) mixture that will be divided equally between port sites
Port site infiltration techniqueBupivacaine 0.5%After the induction of anaesthesia, pre-incisional port-site infiltration will be performed by the same surgeon every time with 20 ml of Local anesthetic (LA) mixture that will be divided equally between port sites
Erector spinae plane blockLidocaine 2%ultrasound guided ESP Block after anaesthesia induction
Port site infiltration techniquePort site infiltrationAfter the induction of anaesthesia, pre-incisional port-site infiltration will be performed by the same surgeon every time with 20 ml of Local anesthetic (LA) mixture that will be divided equally between port sites
Erector spinae plane blockBupivacaine 0.5%ultrasound guided ESP Block after anaesthesia induction
Erector spinae plane blockErector spinae plane blockultrasound guided ESP Block after anaesthesia induction
Erector spinae plane blockUltrasound machine (Mindray DP 9900 plus; Mindray Bio-Medical Electronics, Shenzhen, China)ultrasound guided ESP Block after anaesthesia induction
Primary Outcome Measures
NameTimeMethod
Total postoperative opioid consumption.24 hours postoperatively

Nalbuphine consumption in mg.(equivalent to morphine dose)

Secondary Outcome Measures
NameTimeMethod
Pain scores;Numerical Rating Scale (NRS) at rest and when coughingat 1, 2,4 , 8, 16 and 24 hours postoperatively.

The NRS is a segmented numeric version of the Visual Analog Scale (VAS) in which a respondent selects a whole number (0-10 integers).

•Cumulative postoperative analgesic consumption24 hours postoperatively

Analgesic drug consumption other than nalbuphine in mg.

•Heart Rate (HR)Intraoperatively at 0, 5,10, 20, and 30 minutes. Then every 15 min thereafter till the end of surgery

Heart Rate in beats /min

•Mean Arterial Pressure (MAP)Intraoperatively at 0, 5,10, 20, and 30 minutes. Then every 15 min thereafter till the end of surgery

Mean Arterial Pressure in mmHg

Incidence and severity Postoperative nausea & vomiting (PONV).24 hours postoperatively

Number of patients developing PONV \& PONV Score; (1) No nausea or vomiting, (2) only nausea but no vomiting, (3) single episode of vomiting or persistent nausea, and (4) two or more episodes of vomiting or severe retching.

Trial Locations

Locations (1)

Assiut University hospital

🇪🇬

Assiut, Asyut Governorate, Egypt

© Copyright 2025. All Rights Reserved by MedPath